TrialTherapeutic hypothermia and temperature management2024

Soluble Urokinase-Type Plasminogen Activator Receptor in Comatose Survivors After Out-of-Hospital Cardiac Arrest Treated with Targeted Temperature Management.

John Bro-Jeppesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.